Okumura, Hiroyuki
Tang, Wentao
Iwasaki, Kosuke
Shoji, Shingo
Odaka, Takeo
Nakajima, Atsushi
Funding for this research was provided by:
Astellas Pharma (Not applicable)
Article History
Accepted: 18 August 2020
First Online: 29 August 2020
Compliance with Ethical Standards
:
: H. Okumura and S. Shoji are employees of Astellas Pharma Inc. K. Iwasaki is an employee of Milliman and W. Tang was an employee of Milliman at the time of the study and received funding from Astellas Pharma Inc. T. Odaka and A. Nakajima received an advisory contract fee from Astellas Pharma Inc.
: This study protocol was reviewed by Astellas Medical Affairs Japan Protocol Review Committee and approved. The conduct of the study was based on a protocol that has been published (Registration Number: CRD42018111737) in the PROSPERO International prospective register of systematic reviews [].
: Not available because this study is categorized into secondary data collection based on published data.